The healthcare diagnostics specialist posted its latest set of quarterly figures. This featured a surprise net profit, among other goodies. 10 stocks we like better than Exact Sciences › Cancer ...
Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 15.2% in the morning session after the company reported strong first quarter 2025 results which beat analysts' revenue and ...
The cancer diagnostics specialist might, just might, be on the verge of selling itself. The apparent would-be buyer is a top name in the U.S. pharmaceutical industry. A strategic investor is ...